Eterus Capital has acquired a minority stake in MTBIKER Group
Eterus Capital, a.s. has acquired a minority stake in MTBIKER Group.
Founded in 2008, Eterus Capital is an investor targeting small and medium-sized companies with growth potential, which have successfully proved their business concept. The fund only invests in minority positions while management control always remains in the hands of the original shareholders.
MTBIKER Group operates the biggest cycling portal and e-shop in Slovakia. Around 400,000 people visit the site monthly, of which 200,000 also visit the shop. MTBIKER began its journey on the internet in 1998 and now they are verified by thousands of satisfied customers and over 200,000 registered bikers. In 2022, the company launched a sister portal MTHIKER, which is supposed to be the destination for a community for outdoor lovers and adventurers, as MTBIKER is for cyclists today.
Oaklins’ team in Slovakia acted as the exclusive buy-side advisor in this transaction. The process was very competitive, with other PE players submitting their bids throughout the transaction process.
Talk to the deal team
Related deals
OBI Group has acquired the OBI and individual DIG stores from Migros
As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more